(1)
Khan, S. A. Comparative Cardiovascular Outcomes of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Multicenter Propensity-Matched Cohort Study. Int J Med Stud 2026.